These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 23236017)

  • 1. Weight change associated with antiepileptic drugs.
    Pickrell WO; Lacey AS; Thomas RH; Smith PE; Rees MI
    J Neurol Neurosurg Psychiatry; 2013 Jul; 84(7):796-9. PubMed ID: 23236017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients.
    Zeng K; Wang X; Xi Z; Yan Y
    Clin Neurol Neurosurg; 2010 May; 112(4):291-5. PubMed ID: 20071075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term Effectiveness of Antiepileptic Drug Monotherapy in Partial Epileptic Patients: A 7-year Study in an Epilepsy Center in China.
    Zhu F; Lang SY; Wang XQ; Shi XB; Ma YF; Zhang X; Chen YN; Zhang JT
    Chin Med J (Engl); 2015 Nov; 128(22):3015-22. PubMed ID: 26608980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral problems in children of mothers with epilepsy prenatally exposed to valproate, carbamazepine, lamotrigine, or levetiracetam monotherapy.
    Huber-Mollema Y; Oort FJ; Lindhout D; Rodenburg R
    Epilepsia; 2019 Jun; 60(6):1069-1082. PubMed ID: 31166022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weight issues for people with epilepsy--a review.
    Ben-Menachem E
    Epilepsia; 2007; 48 Suppl 9():42-5. PubMed ID: 18047602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Long-Term Effectiveness of a Monotherapy with Five Antiepileptic Drugs for Focal Epilepsy in Adult Patients: A Prospective Cohort Study.
    Zeng QY; Fan TT; Zhu P; He RQ; Bao YX; Zheng RY; Xu HQ
    PLoS One; 2015; 10(7):e0131566. PubMed ID: 26147937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison and predictors of rash associated with 15 antiepileptic drugs.
    Arif H; Buchsbaum R; Weintraub D; Koyfman S; Salas-Humara C; Bazil CW; Resor SR; Hirsch LJ
    Neurology; 2007 May; 68(20):1701-9. PubMed ID: 17502552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-reactivity of skin rashes with current antiepileptic drugs in Chinese population.
    Wang XQ; Lang SY; Shi XB; Tian HJ; Wang RF; Yang F
    Seizure; 2010 Nov; 19(9):562-6. PubMed ID: 20888266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levetiracetam does not alter body weight: analysis of randomized, controlled clinical trials.
    Gidal BE; Sheth RD; Magnus L; Herbeuval AF
    Epilepsy Res; 2003 Oct; 56(2-3):121-6. PubMed ID: 14642996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic and hormonal disturbances in women with epilepsy on antiepileptic drug monotherapy.
    Kim JY; Lee HW
    Epilepsia; 2007 Jul; 48(7):1366-70. PubMed ID: 17565596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topiramate-induced weight loss depends on level of intellectual disability in patients with epilepsy.
    Iwaki H; Jin K; Fujikawa M; Nakasato N; Kaneko S
    Epilepsy Behav; 2018 Jun; 83():87-91. PubMed ID: 29665571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological outcomes in juvenile myoclonic epilepsy: Support for sodium valproate.
    Chowdhury A; Brodie MJ
    Epilepsy Res; 2016 Jan; 119():62-6. PubMed ID: 26675554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse drug reactions associated with six commonly used antiepileptic drugs in southern China from 2003 to 2015.
    Du Y; Lin J; Shen J; Ding S; Ye M; Wang L; Wang Y; Wang X; Xia N; Zheng R; Chen H; Xu H
    BMC Pharmacol Toxicol; 2019 Jan; 20(1):7. PubMed ID: 30642405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-sensitivity of skin rashes with antiepileptic drug use.
    Hirsch LJ; Arif H; Nahm EA; Buchsbaum R; Resor SR; Bazil CW
    Neurology; 2008 Nov; 71(19):1527-34. PubMed ID: 18981374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced immunoglobulin levels in epilepsy patients treated with levetiracetam, lamotrigine, or carbamazepine.
    Svalheim S; Mushtaq U; Mochol M; Luef G; Rauchenzauner M; Frøland SS; Taubøll E
    Acta Neurol Scand Suppl; 2013; (196):11-5. PubMed ID: 23190286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related pattern of the antiepileptic drug utilization in active epilepsy: a population-based survey.
    Bielen I; Sruk A; Planjar-Prvan M; Cvitanović-Sojat L; Kosicek M; Bergman-Marković B; Baraba R; Butković-Soldo S
    Coll Antropol; 2009 Jun; 33(2):659-63. PubMed ID: 19662794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular risk factors in epilepsy patients taking levetiracetam, carbamazepine or lamotrigine.
    Svalheim S; Luef G; Rauchenzauner M; Mørkrid L; Gjerstad L; Taubøll E
    Acta Neurol Scand Suppl; 2010; (190):30-3. PubMed ID: 20586732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-reported symptoms in patients on antiepileptic drugs in monotherapy.
    Wieshmann UC; Tan GM; Baker G
    Acta Neurol Scand; 2011 Nov; 124(5):355-8. PubMed ID: 21973277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term retention rates of new antiepileptic drugs in adults with chronic epilepsy and learning disability.
    Simister RJ; Sander JW; Koepp MJ
    Epilepsy Behav; 2007 Mar; 10(2):336-9. PubMed ID: 17267290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative retention rates and long-term tolerability of new antiepileptic drugs.
    Chung S; Wang N; Hank N
    Seizure; 2007 Jun; 16(4):296-304. PubMed ID: 17267243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.